SignatureFD’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

SignatureFD’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-115	Closed	-$483	–	3426
2023 Q1	$483	Sell	115 -80	-41%	-$415	﹤0.01%	3103
2022 Q4	$1.17K	Sell	195 -448	-70%	-$2.44K	﹤0.01%	2942
2022 Q3	$4K	Sell	643 -10	-2%	-$62	﹤0.01%	2591
2022 Q2	$4K	Buy	+653	New	+$3.34K	﹤0.01%	2576

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

SignatureFD's CTIC Position: Q2 2023 in Review

SignatureFD sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 115 shares — an estimated $483 sold.

SignatureFD first reported a position in CTIC in Q2 2022 and held it in 4 quarters. The position peaked at $4K in Q3 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

SignatureFD reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
SignatureFD sold 115 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $483.
SignatureFD first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2022 and held it in 4 quarters.
SignatureFD's CTI BioPharma Corp. (DE) Common Stock position peaked at $4K in Q3 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.